search
Back to results

Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea

Primary Purpose

Asthma, Sleep Apnea

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
CPAP machine as a result of sleep study
Sponsored by
National Jewish Health
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthma focused on measuring Asthma, Sleep Apnea, Obesity, CPAP

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adult (>18yrs at the time of recruitment) Body mass index (BMI) ≥ 30 Symptoms suggestive of sleep apnea Epworth Sleepiness Score (ESS) within range Positive sleep study for sleep apnea Exclusion Criteria: Tobacco use within the last 3 months. Presence of other significant comorbid heart or lung disease Presence of another chronic inflammatory disease, such as connective-tissue disease, inflammatory bowel disease, or active infection. Use of systemic steroids, as defined as any prednisone use in the preceding 3 months. Use of leukotriene antagonists or theophylline within the preceding 6 weeks. Presence of severe or uncontrolled sinusitis, such that CPAP therapy will be difficult or uncomfortable. History of significant claustrophobia, uncontrolled psychiatric disease, or anticipated intolerance of CPAP therapy. Night shift workers, or other subjects with significantly altered sleep-wake cycles. Baseline post-bronchodilator FEV1 < 70% predicted. Severe gastroesophageal reflux disease.

Sites / Locations

  • National Jewish Medical and Research Center

Outcomes

Primary Outcome Measures

Systemic inflammatory markers will include IL-6, IL-8, CRP, and TNF-α.
Exhaled breath condensate levels of IL-6 and 8-isporostane will be measured.
BAL (bronchial lavage) fluid cell count and differential, IL-6, IL-8, and TNF- α will be measured.
Endobronchial biopsies to analyze extent and type of inflammatory cell.

Secondary Outcome Measures

Symptoms, albuterol use and daily morning and evening peak expiratory flows from diary cards.
Spirometry measured at three time points: before, during, and after CPAP therapy.
Post-CPAP methacholine for bronchial hyperreactivity

Full Information

First Posted
October 11, 2005
Last Updated
March 27, 2017
Sponsor
National Jewish Health
search

1. Study Identification

Unique Protocol Identification Number
NCT00238069
Brief Title
Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea
Official Title
Effect of CPAP (Continuous Positive Airway Pressure) on Airway Inflammation in Asthmatics With Sleep-Disordered Breathing: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
December 2004 (undefined)
Primary Completion Date
August 2005 (Actual)
Study Completion Date
August 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
National Jewish Health

4. Oversight

5. Study Description

Brief Summary
This is a research study of asthma and sleep apnea. Our hypothesis is that untreated sleep apnea causes inflammation in the lung, which can worsen asthma. We believe treatment of sleep apnea will reduce this inflammation, and improve asthma control. This study will help us better understand what happens to the lung and bronchial tubes before and after treatment of sleep apnea, which could benefit all patients with sleep apnea. This study involves 2 bronchoscopies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma, Sleep Apnea
Keywords
Asthma, Sleep Apnea, Obesity, CPAP

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
CPAP machine as a result of sleep study
Primary Outcome Measure Information:
Title
Systemic inflammatory markers will include IL-6, IL-8, CRP, and TNF-α.
Title
Exhaled breath condensate levels of IL-6 and 8-isporostane will be measured.
Title
BAL (bronchial lavage) fluid cell count and differential, IL-6, IL-8, and TNF- α will be measured.
Title
Endobronchial biopsies to analyze extent and type of inflammatory cell.
Secondary Outcome Measure Information:
Title
Symptoms, albuterol use and daily morning and evening peak expiratory flows from diary cards.
Title
Spirometry measured at three time points: before, during, and after CPAP therapy.
Title
Post-CPAP methacholine for bronchial hyperreactivity

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult (>18yrs at the time of recruitment) Body mass index (BMI) ≥ 30 Symptoms suggestive of sleep apnea Epworth Sleepiness Score (ESS) within range Positive sleep study for sleep apnea Exclusion Criteria: Tobacco use within the last 3 months. Presence of other significant comorbid heart or lung disease Presence of another chronic inflammatory disease, such as connective-tissue disease, inflammatory bowel disease, or active infection. Use of systemic steroids, as defined as any prednisone use in the preceding 3 months. Use of leukotriene antagonists or theophylline within the preceding 6 weeks. Presence of severe or uncontrolled sinusitis, such that CPAP therapy will be difficult or uncomfortable. History of significant claustrophobia, uncontrolled psychiatric disease, or anticipated intolerance of CPAP therapy. Night shift workers, or other subjects with significantly altered sleep-wake cycles. Baseline post-bronchodilator FEV1 < 70% predicted. Severe gastroesophageal reflux disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Martin, MD
Organizational Affiliation
National Jewish Medical and Research Center faculty
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Jewish Medical and Research Center
City
Denver
State/Province
Colorado
ZIP/Postal Code
80206
Country
United States

12. IPD Sharing Statement

Links:
URL
http://www.nationaljewish.org/professionals/research/programs-depts/felt-lab
Description
clinical lab website within National Jewish Medical and Research Center

Learn more about this trial

Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea

We'll reach out to this number within 24 hrs